Literature DB >> 7059356

Enzyme inhibition and the toxic action of moniliformin and other vinylogous alpha-ketoacids.

L T Burka, J Doran, B J Wilson.   

Abstract

The inhibition of two thiamine-requiring enzymes by the potent mycotoxin, moniliformin (1-hydroxycyclobutene-3,4-dione), was investigated. Rat brain transketolase and pyruvate dehydrogenase were inhibited 25 percent by 10-9 M moniliformin. Studies carried out to determine if moniliformin causes enzyme inhibition by reaction with thiamine were negative. Varying the hydroxycyclobutenedione structure by substitution or ring expansion resulted in loss of toxicity and inhibition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059356     DOI: 10.1016/0006-2952(82)90240-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Development of an L6 myoblast in vitro model of moniliformin toxicosis.

Authors:  R Reams; H L Thacker; M Novilla; D Laska; J Horn; D Harrington; W Greenlee; R Vesonder
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

2.  Purified moniliformin does not affect the force or rate of contraction of isolated guinea pig atria.

Authors:  R Y Reams; H L Thacker; D D Harrington; M N Novilla; B Wilson
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

3.  Inhibition of pyruvate dehydrogenase complex by moniliformin.

Authors:  P S Gathercole; P G Thiel; J H Hofmeyr
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.